tering personal relationships between select Swedish biotech executives and American investors. Previous years' programs have featured among others David Brennan, Jacob Wallenberg, the President of Karolinska Institutet Harriet Wallberg-Henriksson, Nobel Laureate Arvid Carlsson and Congresswoman Diana Degett